On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Regulated immune responses
- Membrane protein interactions (1)
- Paired leukocyte receptors
- The Ly49 story (1)
- The Ly49 story (2)
- Summary: paired receptors
- The SIRP family and their ligands
- Specificity of SIRPalpha binding to CD47 (1)
- Specificity of SIRPalpha binding to CD47 (2)
- Specificity of SIRPalpha binding to CD47 (3)
- Failure of SIRP betas to bind CD47
- Mutating the His100 to Asp restores activity
- Why the special binding face?
- Driving force for paired receptor evolution
- The counterbalance theory for paired receptors
- What do the activating receptors bind?
- Pathogen binding to activating receptors
- Role of polymorphisms in paired receptors
- The polymorphisms in SIRPalpha domain 1
- SIRPalpha domain 1 is highly polymorphic
- Why is SIRPalpha domain 1 so polymorphic?
- What about other paired receptors?
- Polymorphisms in LILRB1
- Driving force for paired receptor evolution (1)
- How is SIRPalpha organised at the cell surface?
- SIRPalpha: a protein with 3 IgSF domains
- SIRPalpha-CD47 topology of interaction
- Membrane protein interactions (2)
- Driving force for paired receptor evolution (2)
- SIRPalpha moves to immunological synapse
- Synapses prevent unwanted receptors targeting
- Summary I
- CD200R is another macrophage paired receptor
- CD200-CD200 receptor interaction
- Models for viral homologues of CD200
- Some viral homologues of CD200 bind CD200R
- Pathogen product targeting inhibitory CD200R
- CD200 is a target for leukaemia
- Inhibitory receptors as cancer therapy targets
- Allergic diseases and asthma
- Paired receptors and pathogen environment
- Summary II
- Acknowledgements
Topics Covered
- Immunoregulation and cell surface receptors
- Paired receptors
- Inhibitory
- Activating
- Myeloid cells
- X-ray crystallography
- Protein structure Ig superfamily domains
- Evolution Pathogen pressure
- Host environment interactions
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Barclay, N. (2021, October 12). Macrophage paired receptor interactions [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/HMYP8011.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Neil Barclay has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.